News
A
125.81
+0.74%
0.93
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News
Simply Wall St · 9h ago
FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum
Simply Wall St · 1d ago
Daily Dividend Report: AME,A,GLW,ROK,CSCO
NASDAQ · 2d ago
Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update
Seeking Alpha · 2d ago
Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx
TipRanks · 2d ago
Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys
Seeking Alpha · 2d ago
Agilent Technologies declares $0.255 dividend
Seeking Alpha · 3d ago
Albemarle Non-GAAP EPS of -$0.53 misses by $0.04, revenue of $1.43B beats by $80M
Seeking Alpha · 3d ago
Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share
Dow Jones · 3d ago
Agilent Announces Cash Dividend of 25.5 Cents per Share
Barchart · 3d ago
Frontier Group Non-GAAP EPS of $0.23 beats by $0.10, revenue of $997M beats by $23.45M
Seeking Alpha · 3d ago
Agilent Technologies Says FDA Approves PD-L1 IHC 22C3 pharmDx In Identifying First-Line Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma
Benzinga · 3d ago
Agilent: FDA approves PD-L1 IHC 22C3 pharmDx, Code SK006
TipRanks · 3d ago
Merck's Keytruda gains additional indications for ovarian, fallopian tube carcinoma
Seeking Alpha · 4d ago
Malaysia's January Palm Oil Exports 1.48M Tons; Up 11%, MPOB Says
Dow Jones · 4d ago
Weekly Report: what happened at A last week (0202-0206)?
Weekly Report · 5d ago
Agilent (A) Gets a Buy from Barclays
TipRanks · 5d ago
Agilent’s SLAS2026 Automation Push Might Change The Case For Investing In Agilent Technologies (A)
Simply Wall St · 02/07 11:07
What's Driving the Market Sentiment Around Agilent Technologies Inc?
Benzinga · 02/06 13:00
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase
Simply Wall St · 02/06 02:20
More
Webull provides a variety of real-time A stock news. You can receive the latest news about Agilent Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About A
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.